Anticholinergic approved for COPD
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Survey: Part B Price Negotiation Could have Significant Impact on Providers
Read More
Remote Care Advancement for Heart Failure, COPD and Diabetes Patients
Listen
Intercept Withdraws Ocaliva from Market After FDA Raises Safety Concerns
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
AI-Driven Tool Links Lung Fibrosis to Accelerated Aging in IPF and Aging Research